BEYOND TYPE 1 for BEYOND TYPE 1
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 4, 2022 | — | Replaced |
| 4th Quarter - Amendment | Feb 17, 2022 | — | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Insulin affordability Prescription drug affordability Improving diabetes device access Support for H.R.379 Improving Social Determinants of Health Act of 2021 Support for S.1424 Chronic Disease Management Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTEL MARCHAND APRIGLIANO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.